DiaMedica Therapeutics Schedules Q3 2026 Results and Business Update
The company says it will report third-quarter 2026 financial results and provide a business update on November 13, 2026.
Related stories
Investor Group Led by CEO Charley Biggs Acquires eCamps Sports Network
eCamps Sports Network was acquired from PlayMetrics by an investor group led by CEO Charley Biggs.
M impact | EQUITY | Nov 05, 2026, 01:49 PM UTC
EDB Acquires Altinity to Combine Postgres and ClickHouse Expertise
EDB says the acquisition brings together expertise in Postgres and ClickHouse.
M impact | EQUITY | Nov 05, 2026, 01:49 PM UTC
Papa John's Reports Third-Quarter Revenue Down 10% to $454.8 Million
CEO Todd Penegor said performance was below expectations, while the company delivered positive free cash flow through value, operational execution and cost management.
M impact | EQUITY | Nov 05, 2026, 01:48 PM UTC
Southern Co. Reports Higher Third-Quarter Profit and Revenue
Southern Co. reported third-quarter profit of $2.05 billion, or $1.76 a share, versus $1.71 billion, or $1.54 a share, a year earlier. Revenue also rose as energy demand grew in th
M impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
Disc Medicine Reports Third-Quarter 2026 Financial Results
Disc Medicine reported third-quarter 2026 financial results and provided a business update.
M impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
HCW Biologics Secures Up to $10.0 Million Through Debt Financing
HCW Biologics secured up to $10.0 million in cash through debt financing.
L impact | EQUITY | Nov 05, 2026, 01:45 PM UTC